03611nam 2200505 450 991048195990332120230424115125.03-030-67521-1(CKB)4100000011801752(MiAaPQ)EBC6522074(Au-PeEL)EBL6522074(OCoLC)1243538646(PPN)254726380(EXLCZ)99410000001180175220211013d2021 uy 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierNeuroimaging of Covid-19 first insights based on clinical cases /edited by Simonetta GereviniCham, Switzerland :Springer,[2021]©20211 online resource (92 pages) illustrations3-030-67520-3 Intro -- Acknowledgements -- Contents -- 1: Introduction -- 1.1 How to Read the Atlas -- 2: Background -- 2.1 Pathogenesis of COVID-19 Infection -- 2.1.1 Hyperinflammation -- 2.1.2 Hypercoagulability -- 2.1.3 A Few Final Remarks on the Pathogenesis of COVID-19 -- 2.2 Neurological Manifestations in SARS-CoV-2 Infection -- 2.2.1 Neurological Manifestations in Other Types of Coronavirus -- 2.2.2 Neurological Manifestation: Experience with Novel SARS-CoV-2 Infection -- 2.2.2.1 Epidemiology -- 2.2.2.2 Neuro-Invasiveness and Neurotropism of SARS-CoV-2 -- 2.2.2.3 Neurological Manifestations -- Cerebrovascular Disease (CVD) -- Encephalopathies, Disorders of Consciousness, Altered Mental Status -- Inflammatory CNS Syndromes -- Encephalitis Resulting from Direct SARS-CoV-2 Spreading to the CNS -- Para-Infective and Post-infective Encephalitis in the Absence of CNS Viral Invasion -- Peripheral Neurological Disorders -- References -- 3: Vascular Manifestations in  COVID 19 -- 3.1 Clinical Cases -- References -- 4: Posterior Reversible Encephalopathy Syndrome (PRES) and Meningo-Encephalitis in COVID -- 4.1 Posterior Reversible Encephalopathy Syndrome (PRES) in COVID-19 Setting -- 4.1.1 Brain Imaging in COVID-Related PRES -- 4.1.2 Case Description -- 4.1.2.1 Case 1 -- 4.1.2.2 Case 2 -- 4.1.3 Discussion -- 4.2 Meningo-Encephalitis in COVID-19 Setting -- 4.2.1 Case Description -- 4.2.1.1 Case 1 -- 4.2.1.2 Case 2 -- 4.2.1.3 Case 3 -- 4.2.1.4 Case 4 -- 4.2.2 Discussion -- References -- 5: Possible Thrombotic Microangiopathy Occurring in Patient with CNS Localization of SARS-Cov-2 -- 5.1 Clinical Cases (Figs. 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9 and 5.10) -- References -- 6: Still to Be Explored: Involvement of Other Districts/Organs in COVID-19 Patients -- 7: Brain Imaging Findings in COVID-19 Positive Newborns -- 7.1 Introduction.7.2 Case Description -- 7.2.1 Magnetic Resonance Imaging (MRI) -- References -- 8: Cardiac Involvement in COVID-19 Infection -- 8.1 Cardiac Involvement -- References -- 9: The Neuropathology Spectrum in Deceased Patients with COVID-19 -- References.COVID-19 (Disease)ImagingNervous systemRadiographyCOVID-19thubNeuroradiologiathubLlibres electrònicsthubCOVID-19 (Disease)Imaging.Nervous systemRadiography.COVID-19Neuroradiologia616.2414Gerevini SimonettaMiAaPQMiAaPQMiAaPQBOOK9910481959903321Neuroimaging of Covid-191891075UNINA